EMA Authorised: Arava (leflunomide) — Sanofi-aventis Deutschland GmbH

View source ↗

Summary

The European Medicines Agency authorised Arava (leflunomide) for the treatment of rheumatoid arthritis and psoriatic arthritis, with Sanofi-aventis Deutschland …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• ARAVA (leflunomide)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Rheumatoid;Arthritis, Psoriatic. MAH: Sanofi-aventis Deutschland GmbH. Decision date: 04/09/2025